Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases

The efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with human immunodeficiency virus (HIV) and/or genotype 3 hepatitis C virus (HCV) infection is yet to be clarified. This is because no or only a few patients have been included in Japanese phase 3 trials. We herein report f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sho, Takuya, Suda, Goki, Kimura, Megumi, Shimazaki, Tomoe, Maehara, Osamu, Shigesawa, Taku, Suzuki, Kazuharu, Nakamura, Akihisa, Ohara, Masatsugu, Umemura, Machiko, Izumi, Takaaki, Kawagishi, Naoki, Baba, Masaru, Nakai, Masato, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465017/
https://www.ncbi.nlm.nih.gov/pubmed/30449808
http://dx.doi.org/10.2169/internalmedicine.1856-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465017/
https://www.ncbi.nlm.nih.gov/pubmed/30449808
http://dx.doi.org/10.2169/internalmedicine.1856-18

Ejemplares similares